Details for Patent: 10,076,614
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 10,076,614 protect, and when does it expire?
Patent 10,076,614 protects ONZETRA XSAIL and XHANCE and is included in two NDAs.
This patent has twenty-one patent family members in seventeen countries.
Summary for Patent: 10,076,614
Title: | Nasal delivery devices |
Abstract: | A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject; a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece. |
Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Gordon; Joseph (Mansfield, MA), Leclerc; Michael (Cranston, RI), Mahmoud; Ramy A (Skillman, NJ), Siwinski; Shane (Providence, RI) |
Assignee: | OptiNose AS (Oslo, NO) |
Application Number: | 14/380,801 |
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 10,076,614
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,076,614
PCT Information | |||
PCT Filed | February 25, 2013 | PCT Application Number: | PCT/EP2013/053747 |
PCT Publication Date: | August 29, 2013 | PCT Publication Number: | WO2013/124492 |
International Family Members for US Patent 10,076,614
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013223973 | See Plans and Pricing | |||
Canada | 2865353 | See Plans and Pricing | |||
China | 104428026 | See Plans and Pricing | |||
Denmark | 2817054 | See Plans and Pricing | |||
European Patent Office | 2817054 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |